HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

S Looareesuwan Selected Research

artesunate

9/2010New fixed-dose artesunate-mefloquine formulation against multidrug-resistant Plasmodium falciparum in adults: a comparative phase IIb safety and pharmacokinetic study with standard-dose nonfixed artesunate plus mefloquine.
5/2006Pharmacokinetics of dihydroartemisinin following oral artesunate treatment of pregnant women with acute uncomplicated falciparum malaria.
9/2005An open randomized clinical trial of Artekin vs artesunate-mefloquine in the treatment of acute uncomplicated falciparum malaria.
5/2005An open, randomized trial of three-day treatment with artesunate combined with a standard dose of mefloquine divided over either two or three days, for acute, uncomplicated falciparum malaria.
5/2005Curdlan sulphate in human severe/cerebral Plasmodium falciparum malaria.
9/2004The pharmacokinetics of oral dihydroartemisinin and artesunate in healthy Thai volunteers.
9/2004Therapeutic efficacy of artesunate in Plasmodium vivax malaria in Thailand.
10/2003The pharmacokinetics of atovaquone and proguanil in pregnant women with acute falciparum malaria.
9/2003Monitoring the therapeutic efficacy of antimalarials against uncomplicated falciparum malaria in Thailand.
11/2002Artesunate and mefloquine given simultaneously for three days via a prepacked blister is equally effective and tolerated as a standard sequential treatment of uncomplicated acute Plasmodium falciparum malaria: randomized, double-blind study in Thailand.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password:


S Looareesuwan Research Topics

Disease

44Falciparum Malaria (Plasmodium falciparum Malaria)
09/2010 - 01/2000
35Malaria
09/2007 - 01/2000
10Infection
11/2003 - 03/2000
9Cerebral Malaria
05/2008 - 09/2000
6Vivax Malaria
09/2004 - 06/2000
5Fever (Fevers)
09/2005 - 12/2001
5Parasitemia
09/2004 - 03/2000
2Body Weight (Weight, Body)
09/2010 - 09/2004
2Multiple Organ Failure (MODS)
02/2005 - 03/2003
2Glucosephosphate Dehydrogenase Deficiency
12/2001 - 04/2000
1Tachycardia (Tachyarrhythmias)
04/2011
1Blister (Bulla)
11/2002
1Cholera
12/2001
1Hemolytic Anemia
12/2001
1Splenomegaly
11/2001
1Embolism (Embolus)
11/2001
1Phototoxic Dermatitis (Phototoxicity)
09/2001
1Coma (Comas)
06/2001
1Malnutrition
02/2001
1Pruritus (Itching)
10/2000
1alpha-Thalassemia
04/2000
1beta-Thalassemia (Cooley's Anemia)
04/2000
1Sepsis (Septicemia)
03/2000

Drug/Important Bio-Agent (IBA)

19artesunateIBA
09/2010 - 01/2000
12Mefloquine (Lariam)FDA LinkGeneric
04/2011 - 06/2000
9Antimalarials (Antimalarial Agents)IBA
12/2004 - 06/2000
9artemisinine (artemisinin)IBA
09/2004 - 01/2000
8Chloroquine (Aralen)FDA LinkGeneric
09/2004 - 06/2000
8artemetherFDA Link
09/2003 - 01/2000
7dihydroquinghaosu (dihydroartemisinin)IBA
05/2006 - 09/2000
7Quinine (Quinson)FDA Link
11/2003 - 08/2000
6Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
05/2008 - 06/2000
6lumefantrineFDA Link
09/2003 - 03/2000
5Immunoglobulin E (IgE)IBA
09/2007 - 03/2000
5AntibodiesIBA
12/2001 - 03/2000
4Immunoglobulin G (IgG)IBA
09/2007 - 03/2000
3AntigensIBA
09/2007 - 01/2000
3PrimaquineFDA Link
09/2004 - 12/2001
3artemether-lumefantrine combination (Coartem)FDA Link
09/2003 - 05/2001
3Azithromycin (Zithromax)FDA LinkGeneric
09/2002 - 09/2001
3Tetracycline (Achromycin)FDA LinkGeneric
12/2001 - 09/2001
3Clindamycin (Cleocin)FDA LinkGeneric
11/2001 - 09/2000
2CytokinesIBA
05/2008 - 06/2000
2Immunoglobulins (Immunoglobulin)IBA
09/2007 - 03/2000
2NitrogenIBA
02/2005 - 11/2001
2Atovaquone (Mepron)FDA Link
10/2003 - 09/2000
2Nitric Oxide (Nitrogen Monoxide)FDA Link
11/2001 - 06/2001
2Histidine (L-Histidine)FDA Link
11/2001 - 03/2001
2Doxycycline (Vibramycin)FDA LinkGeneric
09/2001 - 09/2001
2Surface Antigens (Surface Antigen)IBA
07/2001 - 08/2000
2Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA
06/2001 - 01/2000
2halofantrine (Halfan)FDA Link
06/2001 - 09/2000
2Antigen-Antibody Complex (Immune Complex)IBA
09/2000 - 03/2000
1TabletsIBA
09/2010
1T-Cell Antigen Receptors (T-Cell Receptor)IBA
05/2008
1HLA-B Antigens (HLA-B)IBA
03/2007
1Carbon MonoxideIBA
09/2005
1piperaquineIBA
09/2005
1curdlanIBA
05/2005
1Alanine Transaminase (SGPT)IBA
02/2005
1Urea (Carbamide)FDA LinkGeneric
02/2005
13-hydroxyquinidineIBA
11/2003
1L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA
11/2003
1cycloguanilIBA
10/2003
1atovaquone-proguanilIBA
10/2003
1Interleukin-13IBA
10/2003
1Interleukin-4 (Interleukin 4)IBA
10/2003
1Proguanil (Paludrine)FDA Link
10/2003
1Interleukin-3 (Interleukin 3)IBA
10/2003
1Trimethoprim (Proloprim)FDA LinkGeneric
06/2003
1Rifampin (Rifampicin)FDA LinkGeneric
05/2003
1B 31IBA
11/2002
1Acute malariaIBA
05/2002
1arteether (artemotil)IBA
05/2002
1Glucosephosphate Dehydrogenase (Glucose 6 Phosphate Dehydrogenase)IBA
12/2001
1Immunoglobulin M (IgM)IBA
12/2001
1LigandsIBA
11/2001
1Insect RepellentsIBA
10/2001
1DEET (DET)IBA
10/2001
1Hemoglobins (Hemoglobin)IBA
10/2001
1Anti-Bacterial Agents (Antibiotics)IBA
09/2001
1Type II Tumor Necrosis Factor ReceptorsIBA
09/2001
1Methionine (L-Methionine)FDA Link
06/2001
1tebufenozide (Mimic)IBA
10/2000
1Histamine (Histamine Dihydrochloride)FDA Link
10/2000
1Dexamethasone (Maxidex)FDA LinkGeneric
10/2000
1Mannitol (Osmitrol)FDA LinkGeneric
10/2000
1sulfadoxine-pyrimethamine (Fansidar)FDA Link
07/2000
1Interleukin-10 (Interleukin 10)IBA
06/2000
1Thrombopoietin (c-mpl Ligand)IBA
06/2000
1Hemoglobin EIBA
04/2000
1Granulocyte Colony-Stimulating Factor (G-CSF)IBA
03/2000
1ErythropoietinFDA Link
03/2000
1Inflammation MediatorsIBA
03/2000
1anti-IgEIBA
03/2000

Therapy/Procedure

3Aftercare (After-Treatment)
08/2000 - 06/2000
1Immunomodulation
08/2001
1Self Medication
02/2001
1Drug Therapy (Chemotherapy)
12/2000
1Intensive Care (Surgical Intensive Care)
10/2000